Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,463 | 4,145 | 6,062 | 11,944 | 18,317 |
| Receivables | 4 | 1 | 1 | N/A | 4 |
| TOTAL | $4,678 | $6,037 | $8,261 | $12,869 | $18,778 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 2 | 5,532 | 7,214 |
| Other Non-Current Assets | 0 | 0 | 0 | 1,039 | 1,935 |
| TOTAL | $N/A | $N/A | $2 | $6,571 | $9,149 |
| Total Assets | $4,678 | $6,037 | $8,263 | $19,440 | $27,927 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 365 | 597 | 616 | 1,298 | 1,479 |
| Accrued Expenses | 542 | 643 | 1,340 | 3,071 | 3,234 |
| TOTAL | $907 | $1,240 | $1,956 | $4,676 | $5,052 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 864 | 1,225 |
| TOTAL | $N/A | $N/A | $N/A | $864 | $1,225 |
| Total Liabilities | $907 | $1,240 | $1,956 | $5,540 | $6,277 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,601 | 1,601 | 1,601 | 1,605 | 1,605 |
| Common Shares | 2 | 16 | 2 | 241 | 241 |
| Retained earnings | -918,577 | -917,449 | -915,767 | -907,924 | -899,448 |
| TOTAL | $3,771 | $4,797 | $6,307 | $13,900 | $21,650 |
| Total Liabilities And Equity | $4,678 | $6,037 | $8,263 | $19,440 | $27,927 |